Table 2.
Number of new clinical areas identified by classification; full list provided in supplementary material
| Classification | Number of conditions with suitable composite responder endpoints | Number of conditions with single-variable responder endpoints |
|---|---|---|
| Bleeding and transfusion | 2 | 1 |
| Cancera | 6 | 4 |
| Cardiovascular and circulation | 5 | 3 |
| Dentistry and vision | 2 | 1 |
| Gastroenterology | 3 | 1 |
| Infectious diseases | 3 | 0 |
| Lungs and airways | 0 | 2 |
| Mental health and addiction | 3 | 1 |
| Neurology | 2 | 7 |
| Orthopaedics and trauma | 1 | 3 |
| Renal and urology | 2 | 1 |
| Rheumatology | 8 | 3 |
| Unclassified | 2 | 1 |
| Total | 39 | 28 |
If a condition had both composite and non-composite responder endpoints identified, they were only included in the composite column
aExcludes solid tumour oncology (as the utility of the method had previously been highlighted there)